Although the gasotransmitter hydrogen sulfide (H 2 S) generally dilates systemic arteries in mammals, it causes constriction of pulmonary arteries. In isolated rat pulmonary arteries, we have shown that the H 2 S precursor cysteine enhances both hypoxic pulmonary vasoconstriction and tension development caused by the agonist prostaglandin F 2α under normoxic con- ditions. These effects were blocked by propargylglycine (PAG), a blocker of the enzyme cystathionine γ lyase which metabolises cysteine to sulfide. In the present study, we evaluated whether 3-mercaptopyruvate (3-MP), a sulfide precursor which is thought to give rise to sulfide when it is metabo- lised by the enzyme mercaptopyruvate sulfurtransferase, also enhanced contraction. Application of 3-MP prior to hypoxic challenge caused a marked enhancement of HPV which was completely blocked by both L- and D,L-PAG (both 1 mM). Cumulative application of 3-1,000 μM 3-MP during an ongoing contraction to PGF 2α under normoxic conditions also caused a marked increase in tension. Application of D-cysteine (1 mM) also enhanced HPV, and this effect was prevented by both the D-amino acid oxidase inhibitor sodium benzoate (500 μM) and 1 mM L-PAG.
CITATION STYLE
Prieto-Lloret, J., & Aaronson, P. I. (2015). Potentiation of hypoxic pulmonary vasoconstriction by hydrogen sulfide precursors 3-mercaptopyruvate and d-cysteine is blocked by the cystathionine γ lyase inhibitor propargylglycine. Advances in Experimental Medicine and Biology, 860, 81–87. https://doi.org/10.1007/978-3-319-18440-1_10
Mendeley helps you to discover research relevant for your work.